| Issue |
Vis Cancer Med
Volume 3, 2022
|
|
|---|---|---|
| Article Number | 4 | |
| Number of page(s) | 4 | |
| DOI | https://doi.org/10.1051/vcm/2022005 | |
| Published online | 21 October 2022 | |
Supplementary material
Video 1: A case report about precision diagnosis and therapy of advanced lung cancer with rare mutations. The patient has been treated with two kinds of 3rd EGFR-TKI targeted to EGFR mutation plus with Bevacizumab according to the disease progression. The PFS is up to 21 months, and the patient is still with stable disease now.
Download Video: Formats: mp4 (1.7 MB) | webm (847.0 KB) | ogg (2.9 MB) | Original mp4 (1.7 MB)
© The Authors, published by EDP Sciences, 2022
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.